Total Payments
$21,799
2024 Payments
$2,925
Companies
37
Transactions
1,182
Medicare Patients
14,815
Medicare Billing
$1.5M
Payment Breakdown by Category
Food & Beverage$20,722 (95.1%)
Travel$803.65 (3.7%)
Education$273.21 (1.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,722 | 1,153 | 95.1% |
| Travel and Lodging | $803.65 | 2 | 3.7% |
| Education | $273.21 | 27 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $5,033 | 116 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $3,006 | 139 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,408 | 257 | $0 (2024) |
| Amgen Inc. | $1,753 | 101 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,268 | 102 | $0 (2024) |
| PFIZER INC. | $918.21 | 63 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $751.57 | 42 | $0 (2024) |
| Alnylam Pharmaceuticals Inc. | $647.52 | 36 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $580.78 | 38 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $470.40 | 42 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,925 | 161 | E.R. Squibb & Sons, L.L.C. ($594.04) |
| 2023 | $3,347 | 167 | E.R. Squibb & Sons, L.L.C. ($549.96) |
| 2022 | $2,192 | 148 | E.R. Squibb & Sons, L.L.C. ($314.03) |
| 2021 | $1,478 | 86 | Boston Scientific Corporation ($373.31) |
| 2020 | $697.55 | 52 | Boston Scientific Corporation ($277.75) |
| 2019 | $3,734 | 219 | Boston Scientific Corporation ($1,030) |
| 2018 | $2,792 | 164 | BOSTON SCIENTIFIC CORPORATION ($905.31) |
| 2017 | $4,634 | 185 | BOSTON SCIENTIFIC CORPORATION ($2,171) |
All Payment Transactions
1,182 individual payment records from CMS Open Payments — Page 1 of 48
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $26.24 | General |
| Category: Cardiovascular | ||||||
| 12/20/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $5.62 | General |
| Category: Cardiovascular | ||||||
| 12/17/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $5.29 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Cardiology | ||||||
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | AngioDynamics, Inc. | ALPHAVAC (Device) | Food and Beverage | In-kind items and services | $78.36 | General |
| Category: VIT | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/04/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/26/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $5.90 | General |
| Category: Cardiology | ||||||
| 11/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/22/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.08 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/21/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Obesity | ||||||
| 11/18/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: Cardiology | ||||||
| 11/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: DIABETES | ||||||
| 11/15/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/07/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $24.43 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/06/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $23.51 | General |
| Category: Cardiovascular | ||||||
| 11/01/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $9.15 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/25/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $28.45 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/23/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $24.93 | General |
| Category: Cardiovascular | ||||||
| 10/22/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $5.99 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/22/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $3.20 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 41 | 3,061 | 6,218 | $1.6M | $372,841 |
| 2022 | 45 | 3,236 | 6,900 | $1.6M | $376,530 |
| 2021 | 49 | 4,251 | 7,430 | $1.8M | $429,918 |
| 2020 | 47 | 4,267 | 6,443 | $1.4M | $331,476 |
Total Patients
14,815
Total Services
26,991
Medicare Billing
$1.5M
Procedure Codes
193
All Medicare Procedures & Services
193 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 362 | 693 | $325,710 | $92,599 | 28.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 361 | 582 | $215,340 | $52,404 | 24.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 284 | 292 | $193,430 | $42,981 | 22.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 98 | 99 | $173,950 | $35,394 | 20.3% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 40 | 640 | $76,800 | $19,630 | 25.6% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 99 | 198 | $73,656 | $18,733 | 25.4% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 40 | 386 | $62,532 | $14,491 | 23.2% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 40 | 325 | $66,950 | $12,542 | 18.7% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 59 | 236 | $41,064 | $9,717 | 23.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 178 | 182 | $42,406 | $9,487 | 22.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 43 | 43 | $28,208 | $7,450 | 26.4% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 29 | 117 | $25,430 | $6,860 | 27.0% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 113 | 113 | $25,877 | $5,604 | 21.7% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 44 | 80 | $20,700 | $4,951 | 23.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 351 | 433 | $60,620 | $4,687 | 7.7% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 60 | 161 | $13,524 | $2,854 | 21.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 74 | 322 | $5,474 | $2,705 | 49.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $10,962 | $2,656 | 24.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 19 | 19 | $12,122 | $2,533 | 20.9% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 13 | 13 | $9,737 | $2,507 | 25.8% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 37 | 94 | $9,212 | $2,123 | 23.0% |
| 93283 | Programming of dual lead implantable defibrillator system | Office | 2023 | 16 | 25 | $6,750 | $2,009 | 29.8% |
| 93282 | Programming of single lead implantable defibrillator system | Office | 2023 | 19 | 30 | $6,450 | $1,979 | 30.7% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 27 | 68 | $9,656 | $1,853 | 19.2% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 18 | 86 | $7,224 | $1,692 | 23.4% |
About Dr. Bassem Nasser, M.D
Dr. Bassem Nasser, M.D is a Cardiovascular Disease healthcare provider based in Fall River, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1881692952.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bassem Nasser, M.D has received a total of $21,799 in payments from pharmaceutical and medical device companies, with $2,925 received in 2024. These payments were reported across 1,182 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($20,722).
As a Medicare-enrolled provider, Nasser has provided services to 14,815 Medicare beneficiaries, totaling 26,991 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 193 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Fall River, MA
- Active Since 07/12/2005
- Last Updated 04/02/2008
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1881692952
Products in Payments
- ELIQUIS (Drug) $2,848
- WATCHMAN (Device) $1,862
- ENTRESTO (Drug) $1,766
- XARELTO (Drug) $1,268
- Repatha (Biological) $1,135
- GENERAL THERAPIES (Device) $782.58
- GENERAL - THERAPIES (Device) $716.50
- LEQVIO (Drug) $641.36
- ONPATTRO (Drug) $620.62
- CAMZYOS (Drug) $618.92
- Corlanor (Drug) $610.52
- LifeVest (Device) $580.78
- BRILINTA (Drug) $488.64
- Livalo (Drug) $457.66
- GENERAL THERAPIES (Device) $441.01
- GENERAL THERAPIES (Device) $362.40
- Kerendia (Drug) $359.49
- VERQUVO (Drug) $357.99
- Vascepa (Drug) $313.72
- Ozempic (Drug) $284.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Fall River
Zia Kidwai, M.d, M.D
Cardiovascular Disease — Payments: $20,287
Cardiovascular Disease $20,287
Ravi Chander, M.d, M.D
Cardiovascular Disease — Payments: $12,959
Cardiovascular Disease $12,959
Dr. Ann Grady, M.d, M.D
Cardiovascular Disease — Payments: $8,932
Cardiovascular Disease $8,932
Dr. M. Wajid Baig, Md, MD
Cardiovascular Disease — Payments: $2,608
Cardiovascular Disease $2,608
Peter Mandelson, Md, MD
Cardiovascular Disease — Payments: $1,186
Cardiovascular Disease $1,186
Stephen Zuehlke, M.d, M.D
Cardiovascular Disease — Payments: $693.85
Cardiovascular Disease $693.85